Connect Biopharma Holdings Ltd (CNTB)

NASDAQ
5.14
+0.03(+0.59%)
After Hours
5.08
-0.06(-1.17%)
- Real-time Data
  • Volume:
    175,106
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    4.87 - 5.21

CNTB Overview

Prev. Close
5.11
Day's Range
4.87-5.21
Revenue
-
Open
4.92
52 wk Range
4.06-29.27
EPS
-
Volume
175,106
Market Cap
272.54M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
474,327
P/E Ratio
-
Beta
-
1-Year Change
-
Shares Outstanding
53,022,810
Next Earnings Date
-
What is your sentiment on Connect Biopharma Holdings Ltd?
or
Market is currently closed. Voting is open during market hours.

Connect Biopharma Holdings Ltd Company Profile

Employees
62

Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, focuses on the discovery and development of immune modulators for the treatment of serious autoimmune diseases and inflammation. The company’s lead product candidate is CBP-201, an anti-interleukin-4 receptor alpha antibody, which is in Phase IIb clinical trial for the treatment of inflammatory allergic diseases, such as atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyps. Its products also comprise CBP-307, a small molecule modulator of sphingosine 1-phosphate receptor 1, a regulator of T cell mobilization out of lymph nodes into the periphery that is in Phase II for the treatment of autoimmune-related inflammation diseases; CBP-174, a small molecule histamine receptor 3 antagonist for oral administration, which is in a preclinical stage to treat chronic itch associated with skin inflammation; and CBP-233, a preclinical stage humanized antibody against interleukin-33, a cytokine involved in T helper 2 inflammation. The company was founded in 2012 and is headquartered in Taicang, China.

Read More

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyStrong BuyNeutralSell
Technical IndicatorsStrong BuyStrong BuyStrong BuyBuySell
SummaryStrong BuyStrong BuyStrong BuyNeutralSell
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.